Back to Search Start Over

Characterization of Plasmodium falciparum prohibitins as novel targets to block infection in humans by impairing the growth and transmission of the parasite.

Authors :
Saini, Monika
Ngwa, Che Julius
Marothia, Manisha
Verma, Pritee
Ahmad, Shakeel
Kumari, Jyoti
Anand, Sakshi
Vandana, Vandana
Goyal, Bharti
Chakraborti, Soumyananda
Pandey, Kailash C.
Garg, Swati
Pati, Soumya
Ranganathan, Anand
Pradel, Gabriele
Singh, Shailja
Source :
Biochemical Pharmacology. Jun2023, Vol. 212, pN.PAG-N.PAG. 1p.
Publication Year :
2023

Abstract

Graphical abstract representing effect of Roc-A on P. falciparum. We present Roc-A as an efficient ligand targeting PHBs in the mitochondria of the P. falciparum. Upon Roc-A binding, the mitochondria may undergo instability and eventually lead to growth defects of the parasite (created in Biorender.com). [Display omitted] Prohibitins (PHBs) are highly conserved pleiotropic proteins as they have been shown to mediate key cellular functions. Here, we characterize PHBs encoding putative genes of Plasmodium falciparum by exploiting different orthologous models. We demonstrated that Pf PHB1 (PF3D7_0829200) and Pf PHB2 (PF3D7_1014700) are expressed in asexual and sexual blood stages of the parasite. Immunostaining indicated hese proteins as mitochondrial residents as they were found to be localized as branched structures. We further validated Pf PHBs as organellar proteins residing in Plasmodium mitochondria, where they interact with each other. Functional characterization was done in Saccharomyces cerevisiae orthologous model by expressing Pf PHB1 and Pf PHB2 in cells harboring respective mutants. The Pf PHBs functionally complemented the yeast PHB1 and PHB2 mutants, where the proteins were found to be involved in stabilizing the mitochondrial DNA, retaining mitochondrial integrity and rescuing yeast cell growth. Further, Rocaglamide (Roc-A), a known inhibitor of PHBs and anti-cancerous agent, was tested against Pf PHBs and as an antimalarial. Roc-A treatment retarded the growth of PHB1, PHB2, and ethidium bromide petite yeast mutants. Moreover, Roc-A inhibited growth of yeast PHBs mutants that were functionally complemented with Pf PHBs, validating P. falciparum PHBs as one of the molecular targets for Roc-A. Roc-A treatment led to growth inhibition of artemisinin-sensitive (3D7), artemisinin-resistant (R539T) and chloroquine-resistant (RKL-9) parasites in nanomolar ranges. The compound was able to retard gametocyte and oocyst growth with significant morphological aberrations. Based on our findings, we propose the presence of functional mitochondrial Pf PHB1 and Pf PHB2 in P. falciparum and their druggability to block parasite growth. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00062952
Volume :
212
Database :
Academic Search Index
Journal :
Biochemical Pharmacology
Publication Type :
Academic Journal
Accession number :
163745767
Full Text :
https://doi.org/10.1016/j.bcp.2023.115567